follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      HomeHealthHealthcare

      Healthcare

      Companies in the healthcare industry include medical physicians, hospitals, and alternative medicine practitioners. 

      The Healthcare industry covers both mental and physical well being and is focused on the maintenance or improvement of health. Companies that work in prevention, diagnosis, and treatment of disease, as well as illness, injury, and other physical and mental impairments, are found in the healthcare sector.

      Examples include Natera Inc., DarioHealth and Novavax.

      Community Health Systems
      Health

      What are Analysts Saying About Community Health Systems?

      Sep 26 Dylan Bernhardt
      Community Health Systems (NYSE:$CYH) is a medical company that specializes in operating general acute care hospitals and outpatient facilities across the country, but is it a sound investment? Let’s take a look at what analysts ... [Read]
      Impax Laboratories' 'Buy' Rating
      Drug Manufacturers

      Cantor Fitzgerald Restates Impax Laboratories’ ‘Buy’ Rating

      Sep 26 Dylan Bernhardt
      On Monday, research analysts Cantor Fitzgerald restated a ‘Buy’ rating for Impax Laboratories, Inc. (NASDAQ:$IPXL). Cantor Fitzgerald also set a price target of $25.00, indicating a potential 8.70% from the stock’s current position. The rating ... [Read]
      Organovo Holdings, Inc
      Healthcare

      Analysts Take a Look at Organovo Holdings, Inc

      Sep 22 Dylan Bernhardt
      Investors are currently taking a closer look at Organovo Holdings, Inc (NASDAQ:$ONVO), noting encouraging results thus far. The stock currently moved 1.48% up, to a trading price of $2.06. The stock also had 0.69 million ... [Read]
      Iovance Biotherapeutics, Inc.
      Biotechnology

      Iovance Biotherapeutics, Inc. Sets Prices for $50 Million Common Stock Offering

      Sep 21 Dylan Bernhardt
      Iovance Biotherapeutics, Inc (NASDAQ:$IOVA) has announced pricing for their $50 million common stock offering. The company will offer 7,692,308 shares of its common stock at the price of $6.50 per share. Gross profits from this ... [Read]
      VBI Vaccines, Inc.
      Biotechnology

      Zacks Investment Research Upgrades VBI Vaccines, Inc.’s Rating

      Sep 21 Dylan Bernhardt
      In a report published on Tuesday morning, Zacks Investment Research has upgraded its rating of VBI Vaccines, Inc (NASDAQ:$VBIV) from a ‘Sell’ rating to a ‘Hold’. VBIV is a biotechnology company that is focused on ... [Read]
      Impax Laboratories in Talks About Merger
      Drug Manufacturers

      Impax Laboratories in Talks About Merger with Amneal Pharmaceuticals LLC

      Sep 21 Dylan Bernhardt
      The Wall Street Journal has reported Thursday that generic drugmaker Impax Laboratories (NASDAQ:$IPXL) has entered talks with Amneal Pharmaceuticals (Privately Traded) about a possible merger. IPXL is a pharmaceutical company specializing in developing, manufacturing and ... [Read]
      VBI Vaccines
      Biotechnology

      VBI Vaccines’ Rating Upgraded by Zacks Investment Research

      Sep 20 Dylan Bernhardt
      VBI Vaccines Inc (NASDAQ:$VBIV) saw its stock rating with Zacks Investment Research rise from ‘Sell’ to ‘Hold’ in a research note from Tuesday. VBIV is a biopharmaceuticals company that develops new technology focused on expanding ... [Read]
      Best Time to Buy Iovance Biotherapeutics
      Biotechnology

      This is Why Right Now is the Best Time to Buy Iovance Biotherapeutics

      Sep 19 Dylan Bernhardt
      Iovance Biotherapeutics Inc. (NASDAQ:$IOVA) is a huge mover this week as shares have increased 5.10%, or $0.4 during the last trading session. In total, about 568,977 shares have been traded, 39.85% up from the average. ... [Read]
      Spectrum Pharmaceuticals, Inc.
      Biotechnology

      The Road Ahead for Spectrum Pharmaceuticals, Inc.

      Sep 19 Dylan Bernhardt
      Spectrum Pharmaceuticals, Inc. (NASDAQ:$SPPI) experienced a disappointing day during trading on Monday, September 18. The stock dipped -0.69% to a closing price of $10.10. The stock normally trades 894.52 million shares a day, but on ... [Read]
      Drug Manufacturers

      Glaukos Corp Lowers Revenue Expectation, 16-Quarter Streak Coming to an End?

      Sep 14 Jen Jiang
      Glaukos Corp. (NASDAQ:$GKOS) is a medical device manufacturer with an eye on glaucoma. The company’s shares are plundering 16.7% today, after management made some adjustments to this year’s total revenue expectations. The company’s glaucoma-relieving iStent ... [Read]

      Posts pagination

      « 1 … 11 12 13 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767